These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16392324)

  • 21. [Nephroprotection: how to slow the progression of chronic renal insufficiency?].
    Hannedouche T; Krummel T; Parvez-Braun L
    Nephrol Ther; 2005 May; 1(2):135-44. PubMed ID: 16895678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
    Weber MA; Giles TD
    Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention strategies for diabetic nephropathy].
    Romero R
    Nefrologia; 2002; 22(3):225-7. PubMed ID: 12123121
    [No Abstract]   [Full Text] [Related]  

  • 25. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
    Weir MR
    Postgrad Med; 2009 Jan; 121(1):96-103. PubMed ID: 19179817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
    Abassi Z; Winaver J; Feuerstein GZ
    Biochem Pharmacol; 2009 Oct; 78(8):933-40. PubMed ID: 19477166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Battle against the renin-angiotensin system: help from an unexpected party.
    Müller D; Müller DN
    Nephrol Dial Transplant; 2009 Apr; 24(4):1110-2. PubMed ID: 19176687
    [No Abstract]   [Full Text] [Related]  

  • 28. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Katavetin P; Katavetin P
    N Engl J Med; 2009 Oct; 361(14):1410-1; author reply 1411. PubMed ID: 19802919
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy.
    Jacobsen PK; Rossing P; Parving HH
    Nephrol Dial Transplant; 2006 Jul; 21(7):2030-1. PubMed ID: 16449277
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renal protective therapy in diabetic nephropathy. Available evidence].
    Rodríguez Pérez JC; Rodríguez Esparragón FJ; Hernández Perera O; Plaza C; Palop L
    Nefrologia; 2001; 21 Suppl 3():58-65. PubMed ID: 11642209
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
    White KE
    Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
    Rossing P; Parving HH; de Zeeuw D
    Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
    [No Abstract]   [Full Text] [Related]  

  • 37. Are oral contraceptives associated with increased renin-angiotensin activity and risk of nephropathy in diabetic women?
    Wolf G
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):78-9. PubMed ID: 16932398
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 39. Promotion, prediction, and prevention of progression in diabetic nephropathy.
    Rossing P
    Dan Med Bull; 1998 Sep; 45(4):354-69. PubMed ID: 9777288
    [No Abstract]   [Full Text] [Related]  

  • 40. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK; Epstein M
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.